Celiac Disease and Its Impact on Liver‐Related Outcomes in Patients With All‐Cause Cirrhosis: The CELIHEP Study
Journal of Gastroenterology and Hepatology · 2025
DOI: 10.1111/jgh.70082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2025. Verfasst von Ankit Agarwal und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi, India. Hauptthemen laut MEDLINE: Celiac Disease, Liver Cirrhosis. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Background and Aims Celiac disease (CeD) is a multisystem disease and may coexist in patients with cirrhosis. We aimed to assess (1) CeD prevalence in all‐cause cirrhosis, (2) the impact of a gluten‐free diet (GFD) on liver‐related outcomes in definite CeD, and (3) characteristics and follow‐up of patients with positive celiac serology and cirrhosis without enteropathy.
Methods
A total of 1959 consecutive patients with cirrhosis were screened for CeD using IgA anti‐tissue transglutaminase antibody. All those having elevated anti‐tTG Ab underwent anti‐endomysial Ab testing and duodenal biopsies. Patients with definite CeD matched with those without CeD (1:4; CeD: no CeD matched for age, sex, baseline CTP, and MELD) were initiated on GFD plus standard of care (SOC) and SOC and followed up for 1 year.
Results
Definite CeD was identified in 35 of 1959 (1.8%; 95% CI: 1.2%–2.4%) ( n = 35; mean age: 37.3 ± 12.3; Child–Pugh Stage A/B/C: 17.1%/57.1%/25.7%; median MELD 19 [IQR: 17–22]), whereas the prevalence of positive celiac serology without enteropathy was 140 of 1959 (7.2%; 95% CI: 6.0%–8.3%). New‐onset liver decompensations (34.3% vs. 44.3%) and mortality (17.1% vs. 13.6%) were similar in patients with CeD on GFD ( n = 35) and the matched ( n = 140) cohort without CeD over 1 year, but liver stiffness measurement decreased significantly in patients with CeD (28.5 ± 14.3 vs. 41.2 ± 18.31; p = 0.001). Patients with definite CeD showed normalization of celiac serology on GFD. One‐year follow‐up IgA tTG normalized in 88 of 122 (72.1%) patients with positive celiac serology without enteropathy without GFD.
Conclusion
Patients with cirrhosis of the liver, irrespective of underlying etiology, should be screened for CeD. Early diagnosis of CeD and GFD may improve prognosis and clinical outcomes in patients with cirrhosis of the liver.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi, India.
- Department of Gastroenterology, Command Hospital (AF), Bengaluru, India.
- Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
ORCID-Profile: Ankit Agarwal, Prasenjit Das, Shalimar, Vineet Ahuja, Govind K Makharia
Zitieren
APA
Agarwal, A., Pachisia, A. V., Agarwal, S., Mehta, S., Kumari, A., Ahmed, A., Sharma, S., Kumar, S., Mehra, L., Das, P., Shalimar, Ahuja, V., & Makharia, G. K. (2025). Celiac Disease and Its Impact on Liver‐Related Outcomes in Patients With All‐Cause Cirrhosis: The CELIHEP Study. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70082
Vancouver
Agarwal A, Pachisia AV, Agarwal S, Mehta S, Kumari A, Ahmed A, et al. Celiac Disease and Its Impact on Liver‐Related Outcomes in Patients With All‐Cause Cirrhosis: The CELIHEP Study. Journal of Gastroenterology and Hepatology. 2025. doi:10.1111/jgh.70082
BibTeX
@article{Agarwal2025,
author = {Agarwal, Ankit and Pachisia, Aditya Vikram and Agarwal, Samagra and Mehta, Shubham and Kumari, Alka and Ahmed, Anam and Sharma, Sonu and Kumar, Sambuddha and Mehra, Lalita and Das, Prasenjit and Shalimar and Ahuja, Vineet and Makharia, Govind K},
title = {Celiac Disease and Its Impact on Liver‐Related Outcomes in Patients With All‐Cause Cirrhosis: The CELIHEP Study},
journal = {Journal of Gastroenterology and Hepatology},
year = {2025},
doi = {10.1111/jgh.70082}
}
EUVIMED